NCT03596138

Brief Summary

Angular measurement of deviation is an essential element in the clinical evaluation of strabic patients. It is performed by orthoptic methods. However, studies show that the same patient presents a great variability of his angular measurement between 2 consultations, and between 2 observers. Automated angle measurement is a recent concept that aims to overcome the defects of subjective angle measurement by alternate occlusion test and prismatic bar. Improvements made by these devices would provide reliable, objective and reproducible measurements of the angle of deviation by increasing the accuracy of strabal angle assessment, improving decision making and surgical follow-up, decreasing inter-examiner variability and variability over time, and facilitating data comparison to improve scientific publication possibilities. The Gazelab® device is a video-oculograph combined with a laser projection system and an infrared camera. It allows an objective angular evaluation, in non-dissociating physiological conditions, possible even in the absence of binocular vision and allows an analysis of the deviation in all positions. There is extremely little data in the literature on automated measuring devices. The Gazelab tool is still little known in the strabology discipline and seems to have a number of advantages over other devices. The interest of this examination towards this pathology led the ophthalmology department to use it in the current practice, and since recently it is an act nomenclaturé.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 23, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

September 4, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2019

Completed
Last Updated

November 25, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

July 10, 2018

Last Update Submit

November 23, 2022

Conditions

Keywords

angle measurementautomatedstrabismus

Outcome Measures

Primary Outcomes (1)

  • Intra-class correlation coefficient

    Intra-class correlation coefficient calculated on the 4 measures (2 of each technique) of each patient taken at time 1 by the same assessor.

    12 months

Secondary Outcomes (2)

  • Intra-class correlation coefficient using measurements

    12 months

  • Intraclass correlation coefficient using time 1 and time 2 measurements

    12 months

Interventions

Compare the results of the Gazelab to the alternate occlusion by prism bar (standard gold) examiners.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Strabismus is a pathology that affects 2 to 4% of the French population. The Ophthalmology Department sees 200 adult patients with strabismus per month. In 6 months it will be easy to include in 30 months 30 patients of convergent strabismus and 30 of divergent strabismus. For patients with eye strain who do not have eye refractive errors the Department of Ophthalmology sees 2000 patients per month, to include these 30 patients in 6 months. Since this study is a prospective non-interventional research study, the patient may be part of a biomedical research study.

You may qualify if:

  • Patients over 18 years of age
  • Strabic convergent or divergent patients or patients requiring an oculomotor check-up in their follow-up consultation
  • Patient giving oral consent to this study

You may not qualify if:

  • Patient with medical follow-up impossible,
  • Impossibility to install Gazelab equipment for anatomical reasons of the head (craniostenosis...)
  • No ocular fixation.
  • Major without freedom under guardianship or trusteeship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Nantes

Nantes, 44000, France

Location

MeSH Terms

Conditions

Strabismus

Condition Hierarchy (Ancestors)

Ocular Motility DisordersCranial Nerve DiseasesNervous System DiseasesEye Diseases

Study Officials

  • Pierre LEBRANCHU, Dr

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2018

First Posted

July 23, 2018

Study Start

September 4, 2018

Primary Completion

April 29, 2019

Study Completion

April 29, 2019

Last Updated

November 25, 2022

Record last verified: 2022-11

Locations